Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Asian Markets Slide as Gulf Tensions Lift Oil Nvidia Earnings in Focus Jim Cramer Rising Bond Yields Pose a Growing Risk to Stock Market Rally Home HFBL Earnings Outlook Key Metrics for Q3 2025 Cisco Posts Best Day Since 2011 on Strong AI Demand CEO Says Tech Entering Networking Supercycle US Productivity Growth Slows in Q4 as Unit Labor Costs Accelerate Gift Nifty Discount Signals Cautious Open for Indian Markets Global Rally Offers Mixed Cues Gen Zs Bargain Hunt Fuels Growth for Discount Retailers Walmart and Ross Hitek Global Files Form 6K with SEC on May 26 How a Roth Conversion Ladder Could Help a 52YearOld Access 40000 Annually PenaltyFree at Age 57 Semiconductor ETF SMH Leads Daily Inflows Amid AIDriven Chip Demand Lightbridge Corporation LTBR Q1 2026 Earnings Net Loss of 020 Per Share Continues Development Phase TeraWulf Inc WULF Q1 2026 Earnings Massive EPS Miss as Bitcoin Mining Headwinds Persist KNOT Offshore Partners Q4 2025 Earnings Significant EPS Miss Amid Challenging Market Conditions MSCI Q1 2026 Earnings Slight EPS Beat Supports Positive Market Response BTDR Q1 2026 Earnings EPS Miss Exceeds 73 as Mining Headwinds Persist LAMR Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response Inspired Entertainment INSE Tests Support After 13 Decline Cushman Wakefield CWK Edges Lower Amid Real Estate Sector Headwinds Sylvamo Corporation SLVM Holds Near 38 as Traders Eye Key Resistance Levels Larimar Therapeutics LRMR Edges Lower as Stock Tests Key Support Zone Evotec ADR Slides 43 as Selling Pressure Tests Key Support Levels ATYR Q1 2026 Earnings Narrower Loss Surprises as Biotech Advances Pipeline Without Revenue Black Stone Minerals Q1 2026 Earnings EPS Misses Estimates Significantly as Royalty Income Falls Short SKYX Q1 2026 Earnings EPS Falls Short of Estimates Amid Ongoing Development TuHURA Biosciences Inc Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline ATAT Q1 2026 Earnings Strong EPS Beat of 25 Despite Stock Pullback